EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR

Delisted

EUCR was delisted on the 26th of April, 2023.

Back to rankings

39 hedge funds and large institutions have $64.6M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$15K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.76M
2
+$2.96M
3
+$2.27M
4
Bank of America
Bank of America
North Carolina
+$1.39M
5
CIM
Cowen Investment Management
New York
+$729K

Top Sellers

1
-$3.22M
2
-$833K
3
-$663K
4
MP
Mangrove Partners
Connecticut
-$313K
5
BlackRock
BlackRock
New York
-$243K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$9.76M
2
$8.79M
3
$5.86M
4
$4.67M
5
$4.23M
6
$3.9M
7
$3.46M
8
$2.27M
9
$1.95M
10
$1.95M
11
$1.64M
12
$1.39M
13
$1.22M
14
$1.14M
15
$1.04M
16
$1.02M
17
$976K
18
$976K
19
$976K
20
$976K
21
$766K
22
$722K
23
$722K
24
$701K
25
$654K
1
2